Source: NS Medical Devices

BioStable Science & Engineering: BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device

The post BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device appeared first on NS Medical Devices.

Read full article »
BioStable Science & Engineering's Competitors | BioStable Science & Engineering's News | BioStable Science & Engineering's Financials
Stay up-to-date with the latest news on BioStable Science & Engineering
Est. Annual Revenue
$25-100M
Est. Employees
100-250
John Wheeler's photo - President & CEO of BioStable Science & Engineering

President & CEO

John Wheeler

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on BioStable Science & Engineering